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A B S T R A C T
Dent-2 disease is an X-linked renal tubulopathy associated with mutations in OCRL gene. It is characterized by
low-molecular weight proteinuria, hypercalciuria, nephrolithiasis/nephrocalcinosis and progressive renal failure. Pa-
tients may have some extra-renal symptoms of Lowe syndrome, such as peripheral cataracts, mental impairment, stunted
growth or elevation of creatine kinase/lactate dehydrogenase. Our patient was suspected to suffer from Dent disease at 8
months of age because of proteinuria and hypercalciuria. He had no prominent extra-renal symptoms. OCRL mutation
in exon 1 (c.217_218 del TT p.L73F, fs X1) was found. He was treated with amiloride+hydroclorthiazide and citrate with
good results in reducing calciuria. His renal ultrasound, ophthalmologic and cardiologic examinations, mental develop-
ment and other laboratory findings are normal till date.
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Introduction
Dent disease1 is an X-linked tubulopathy character-
ized by low-molecular weight (LMW) proteinuria (in
100%), hypercalciuria (in 90%), nephrolithiasis/nephro-
calcinosis (in 75% of the patients) and progressive renal
failure. The disorder has been reported in around 250
families, however, its prevalence is still unknown2. Aro-
und 60% of the patients have mutations in the CLCN5
gene. They have Dent-1 disease caused by mutations af-
fecting the voltage-gated chloride channel and chloride/
proton antiporter (CIC-5), predominantly expressed in
the proximal tubule and a-intercalated cells of the col-
lecting duct3. About 15% of patients have mutations in
the OCRL gene located on chromosome Xq25, which also
causes Lowe oculocerebrorenal syndrome4. There is a
phenotypic continuum within patients with Dent-2 dis-
ease and Lowe syndrome. Affected children may have
some of the extra-renal symptoms of Lowe syndrome,
such as peripheral cataracts, mental impairment, stun-
ted growth or elevation of creatine kinase/lactate dehy-
drogenase3,4. The OCRL protein localizes to lysosomes
and the trans-Golgi network5, early endosomes, plasma
membrane ruffles and clathrin-coated trafficking inter-
mediates. It works as a phosphoinositol 5-phosphatase
that helps regulate the pools of phosphatidyl-inositol
4,5-bisphosphate in the cell6. The OCRL protein is ex-
pressed in several tissues, including the kidney, eye and
brain that are clinically affected in Lowe syndrome5.
Shrimpton et al.7 proposed a model in which the different
mutation spectra for Dent-2 disease versus Lowe syn-
drome reflects an underlying mechanism that explains
the phenotypic differences between the two diseases. Al-
most all Dent-2 mutations fall into two classes: either
mild, with OCRL expressed but functioning at a reduced
level (missense mutations in the phosphatase domain) or
truncating mutations, with little or no expression or
function when studied in skin fibroblasts (frameshift and
stop mutations in exons 1–7)8. Two mutations initially
reported as causing Dent-2 disease were identified in pa-
tients with Lowe syndrome thus extending the clinical
variability of OCRL mutations3. All possible phenotypic
variabilities, treatment options and prognosis of patients
with Dent-2 disease are still not fully understood.
Case Report
Our patient is a boy born in March 2007. His family
history is negative for kidney diseases. His birth weight
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was 3250 g and length 49 cm. He was treated for bac-
teriuria (E. coli) in the maternity ward. At the age of 1.5
month he was admitted to hospital because of urinary
tract infection. After that he had persistent proteinuria
and hematuria so he was sent to our Department of
Nephrology. At the admission he was in the eighth month
of life. His body mass was 7100 g and length 68 cm. He
had a mild shoulder girdle muscle hypotonia, large and
protruding ears, epicanthus and telecanthus, smaller
mandible and longer filtrum. Besides that, he looked
healthy. From the laboratory tests performed, we high-
lighted hypercalciuria (up to 8.29 mg/kg/24 hours or cal-
cium/creatinine ratio up to 2.1), proteinuria from 0.59 g
up to 2.46 g in 24 hours, urinary albumin 314.9 mg/l, uri-
nary b2 microglobuline 3.84 mg/l and serum PTH<0.2
pmol/l. Renal ultrasound and voiding cystourethrogra-
phy, performed because of recurrent urinary tract infec-
tions, showed normal findings as well as cardiologic and
ophthalmologic examination. At that time, we suspected
that the boy was suffering from Dent disease. At the age
of 17 months, he was admitted to our Department for the
second time. He had persistent hypercalciuria and tubu-
lar proteinuria. Renal scintigraphy showed a symmetri-
cal tubular damage. We performed renal biopsy and
found histologically normal glomeruli and densely pa-
cked tubules. Interstitium was only at two places perme-
ated by abundant connective tissue. Patient’s mother
and his 3.5 years old brother had normal global renal
function and renal ultrasound finding. They had no
hypercalciuria or proteinuria. At the age of 17 months,
we started to treat our patient with combination of
amiloride and hydrochlorthiazide and citrate. When his
was 2.5 years old, genetic analysis was completed and
OCRL mutation in exon 1 (c.217_218 del TT p.L73F, fs
X1) was found, thereby providing evidence that he is af-
fected with Dent-2 disease. This variant was formerly re-
ported as c.166_167 del TT p.L56D, fs X57. We also con-
firmed that the patient’s mother is a carrier and that his
brother and grandmother do not have this mutation.
When our patient was 3 years old he underwent brain
magnetic resonance imaging which showed normal find-
ing. We continued therapy with diuretics and citrate but
we stopped giving him vitamin D. During year 2010 cal-
cium/creatinine in his spot urine was 0.61, 0.95, 0.93 and
0.83. At his last control (age 3 years and 10 months) he
had normal global renal function and renal ultrasound.
Proteins were 0.83 g in a 24-hours urine sample, a1
microglobuline 185 mg/l and urine calcium/creatinine ra-
tio between 0.36 and 0.65 (in mmols), calcium pro kilos
in 24-hours urine was 1.89 mg (Table 1).
Discussion
Although, since 1964, when Dent and Friedman1 re-
ported 2 boys with rickets associated with renal tubular
damage characterized by hypercalciuria, proteinuria, hy-
perphosphaturia and aminoaciduria, many authors have
written about the phenotypic variability and new gene
mutations2–4,7,9,10, treatment options9,11,12 and prognosis
of patients with Dent disease, it is still a challenge. There
is a wide overlap of renal symptoms between Dent-1 and
Dent-2 disease and Lowe syndrome3. Analysis of OCRL
mutations show that most Dent 2 mutations fall into two
classes that do not overlap with Lowe mutations7. On the
other hand, it must be kept in mind that mild and severe
presentations of Lowe syndrome together with pure re-
nal forms of Dent disease were associated with a com-
plete loss of the OCRL enzymatic activity. A possible ex-
planation of this clinical variability might be the presence
of modifying factors (compensatory phosphatases, inter-
acting proteins etc) whose expression will depend on the
genetic background of the different patients13. Nephro-
calcinosis seems to be more prevalent in Dent-1 disease
and renal tubular acidosis, aminoaciduria and renal fail-
ure in Lowe syndrome. Patients with Dent-2 disease
show an intermediate phenotype. Nephrolithiasis usu-
ally takes the form of nephrocalcinosis3. It is thought
that the decline in renal function may be partially due to
the infection and obstruction. Authors reported connec-
tion between hypercalciuria and reccurent urinary tract
infections (Biyikli et al.) and some noticed that reduction
in urinary calcium excretion resulted in no futher infec-
tions (Vachvanichsanong et al.)14. This however, cannot
be the sole reason. Some authors reported interstitial fi-
brosis, glomerular hyalinosis, tubular cell changes and
focal glomerulosclerosis found at renal biopsy15,16. Given
this, efforts have been made in defining the best treat-
ment that would suppress hypercalciuria and the forma-
tion of stones, but also have protective action in terms of
delaying interstitial fibrosis and renal failure2,9,11,12.
Treatment with thiazide diuretics in combination with
amiloride, citrate and angiotensin-converting enzyme in-
hibitor might be useful9.
Our patient was suspected to suffer from Dent disease
at 8 months of age because of LMW proteinuria and
hypercalciuria. He did not have any prominent extra-re-
nal manifestations except mild hypotonia. OCRL muta-
tion in exon 1 (c.217_218 del TT p.L73F, fs X1) was
found. This mutation was previously discovered in one
patient by A. E. Shrimpton and colleagues in 20097.
Their patient was 2.5 years old at the time of diagnosis,
he had LMW proteinuria, hypercalciuria and hematuria.
His renal function was normal, he had no renal stones,
no cataracts, no mental impairment or hypotonia. He did
not have aminoaciduria, glycosuria, rickets, hypokalemia
and hypomagnesemia at the age of diagnosis, the same as
our patient. Although there is currently no therapeutic
modality which was shown to slow the progression of re-
nal disease in patients with Dent-2 disease, we started
treatment with amiloride+hydroclorthiazide and K-Na
citrate and got a good response in reducing calciuria.
Therapy was discontinued from October 2009 by Janu-
ary 2010 so calciuria increased to over 5 mg/kg/day. After
the reintroduction of drugs calciuria is now again within
acceptable limits for age17,18 and circumstances. His crea-
tinine, plasma bicarbonate and serum electrolyte levels
are within normal values. We observed that the value of
copper in serum was several times on the top or slightly
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above the upper limit of normal ranges, for which we
have no explanation. We noticed that the boy is some-
what less advanced in body weight and height (5th–10th
centile for age). According to the article of Bökenkamp
and colleagues, patients with Dent-2 disease and Lowe
syndrome were shorter than those with Dent-1 disease3.
Psychological testing at age 15 months and 3 years re-
corded appropriate mental development for age. His re-
nal ultrasound, ophthalmologic and cardiologic examina-
tion remained normal. In a previous study, patients hav-
ing Dent-2 disease with eye involvement were aged 13
and 6 years in the time of diagnosis3 and were older than
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TABLE 1
MAJOR FINDINGS AND TESTS DURING THE FOLLOW-UP OF PATIENT






Creatinine (mmol/l) 41 37 37 50 51 53
(ref. val.) 35–62 35–62 35–62 35–62 35–62 44–71
Plasma bicarbonates
(mmol/l)
22 23.1 25.4 20.7 25.1 22.7
(ref. val.) 21–27 21–27 21–27 21–27 21–27 21–27
LDH (U/l) 304 – 334 293 355 315
(ref. val.) 150–360 150–360 150–360 150–360 150–360 150–360
CK (U/l) 57 – 255 101 212 161
(ref. val.) 60–305 60–305 60–305 60–305 60–305 75–230
Serum electrolytes normal normal normal normal normal normal
Copper (mmol/l) 17.4 28.9–30.8 25.2 25.7 23.0 25.5
Calciuria (mg/kg/day) 8.29 5.17 5.01 2.47 5.03 1.89
(ref. val.)
 5    4  4  4 <4
Ca/cr (mmol)
2.10 1.20–4.94 2.14 0.48 0.71–2.01 0.36–0.65
(upper limit) 1.69 1.69 1.18 1.18 1.18 1.18
Proteinuria (g/dU) 2.46 0.83 0.80 0.17 0.92 0.83
(ref. val.)
 0.15  0.15  0.15  0.15  0.15 <0.15
b2 microglob. (mg/l) 3.84 3.12 – 2.17 – a1=185
(ref.val.) 0.8–2.2 0.8–2.2 0.8–2.2 0.8–2.2 0.8–2.2 a1 15
Glycosuria no no no no no no
Aminoaciduria no no – no – –
PTH (pmol/l) <0.2 1.7 <0.2 <0.2 – 1.3
(ref.val.) 1–6 1–6 1–6 1–6 1–6 1–6
25-OH vit. D (nmol/l) – – 80.67 69.79 30.71
(ref. val.) 75 75 75 75 75 75
Renal ultrasound normal normal normal normal – normal
Ophtalmologic examination normal normal – normal – –
Cardiologic examination normal ECG Normal – normal – –
Weight (kg) 7.1 10 10.5 11.7 13.3 14
(percentile) <5 5–10 5–10 5–10 10–25 10–25
Height (cm) 68 74 79 90 94 95
(percentile) 10–25 <5 <5 10–25 10–25 5–10
Treatment
ailoride-hydrochlorthiazide
and K-Na citrate no
started 16. 10.
2008.
















(ref.val.) = referent values for age
our patient. Also, renal biopsy in our patient did not re-
veal the changes that have been described by other
authors15,16. The diagnosis was established in a very
young patient so it is possible that other phenotypic fea-
tures may manifest later in life. Or he would not have de-
veloped them anyway? Can we slow the progression of
the disease? We will continue treatment with diuretics
and citrate and naturally, regular controlling of our pa-
tient. In the future we will consider the introduction of
ACE inhibitors.
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DJE^AK SA DENT-2 BOLE[]U
S A @ E T A K
Dentova bolest tip 2 je X-vezana tubulopatija udru`ena s mutacijama u OCRL genu. Karakterizirana je niskomole-
kularnom proteinurijom, hiperkalciurijom, nefrolitijazom/nefrokalcinozom i progresivnim bubre`nim zatajenjem. Bo-
lesnici mogu imati i neke ekstrarenalne simptome vezane uz sindrom Lowe, kao {to su periferna mrena, mentalno
o{te}enje, slabiji rast i povi{enje vrijednosti enzima kreatin kinaze/laktat dehidrogenaze. U na{eg bolesnika se posum-
njalo da boluje od Dentove bolesti u dobi od 8 mjeseci zbog proteinurije i hiperkalciurije. Nije imao zna~ajnijih eks-
trarenalnih simptoma. Na|ena je OCRL mutacija u eksonu 1 (c.217_218 del TT p.L73F, fs X1). Lije~en je kombinacijom
amilorida i hidroklortiazida te citratima s dobrim rezultatima u smanjivanju kalciurije. Ultrazvuk bubrega, okulisti~ki
i kardiolo{ki pregledi, mentalni razvoj kao i drugi laboratorijski nalazi su mu do sada uredni.
